Tom Boyles to Treatment Outcome
This is a "connection" page, showing publications Tom Boyles has written about Treatment Outcome.
Connection Strength
0,657
-
Why do clinical trials of Xpert® MTB/RIF fail to show an effect on patient relevant outcomes? Int J Tuberc Lung Dis. 2017 03 01; 21(3):249-250.
Score: 0,454
-
Factors influencing retention in care after starting antiretroviral therapy in a rural South African programme. PLoS One. 2011 May 03; 6(5):e19201.
Score: 0,076
-
Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia: A Randomized Clinical Trial. JAMA Netw Open. 2024 Dec 02; 7(12):e2448215.
Score: 0,049
-
Treating drug-resistant tuberculosis in an era of shorter regimens: Insights from rural South Africa. S Afr Med J. 2023 Nov 06; 113(11):47-56.
Score: 0,045
-
Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL (WRHI 052): a randomised, open-label, phase 3, non-inferiority trial. Lancet HIV. 2019 07; 6(7):e428-e437.
Score: 0,033